Colombia's House of Representatives has passed a constitutional reform bill aimed at regulating the use of marijuana among adults, according to a report by Colombian news outlet Portafolio on October 9th.
Representatives Juan Carlos Losada from the Liberal Party of Colombia and Senator María José Pizarro from the Historical Agreement party are the initiators of this bill, as they aim for the legalization of the purchase and sale of marijuana within Colombia. Despite the use of marijuana being legal according to Colombian regulations, its buying and selling remain prohibited.
Juan stated that this is "the first step in advancing the failed drug policy reform." He has previously explained multiple times that a situation where a drug can be legally used but illegally purchased creates an "opportunity" for the mafia, as individuals with the right to use the drug are forced to resort to the illegal market.
Carlos Ardila, a participant in the proposal and a member of the Free Party, expressed gratitude for the approval by the House of Representatives. He maintained that "we are changing a failed strategy, turning it into a strategy focused on health and education. This will be our approach in dealing with marijuana going forward."
Afterwards, the project will be handed over to the first committee of the Senate for a second round of eight debates, as constitutional reform must go through these discussions.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
